VALYSTR · Stock research
Listed on NasdaqGS. What the market is pricing into HUTCHMED (China) Limited (HCM) in the Healthcare sector: implied growth, valuation scenarios, SEC-filed financials, and what has moved the stock.
Healthcare · Pharmaceutical Preparations · market value about $2.3B · P/E 130.8 · revenue $549M (as of 2026-11-04)
Opening the full page… All companies · Research guides · What a reverse DCF shows